Ignite Creation Date:
2024-05-06 @ 3:57 AM
Last Modification Date:
2024-10-26 @ 11:41 AM
Study NCT ID:
NCT02411565
Status:
TERMINATED
Last Update Posted:
2019-01-23
First Post:
2015-04-03
Brief Title:
Fermented Wheat Germ Extract in Women With Ovarian Cancer
Sponsor:
H Lee Moffitt Cancer Center and Research Institute
Organization:
H Lee Moffitt Cancer Center and Research Institute
Study Overview
Official Title:
A Pilot Randomized Placebo-Controlled Trial of Fermented Wheat Germ Extract in Women With Ovarian Cancer
Status:
TERMINATED
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Drug manufacturing issues
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of this Pilot Study is to test the safety tolerability and quality of life in women who take Fermented Wheat Germ Extract FWGE to determine if an active form of FWGE can be detected in the blood and determine whether short-term therapy with FWGE has any effect on the tumor marker cancer antigen 125 CA-125
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None